Black Diamond Therapeutics annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Black Diamond Therapeutics Debt-to-Assets Ratio Growth & History (BDTX)
Black Diamond Therapeutics's debt-to-assets ratio was 0.13 for fiscal 2025.
View full Black Diamond Therapeutics company overviewBlack Diamond Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.13 | −0.05 | −27.40% |
| 2024 | 2024-12-31 | 0.18 | 0.02 | +13.38% |
| 2023 | 2023-12-31 | 0.16 | −0.02 | −11.41% |
| 2022 | 2022-12-31 | 0.18 | 0.06 | +51.37% |
| 2021 | 2021-12-31 | 0.12 | 0.09 | +348.72% |
| 2020 | 2020-12-31 | 0.03 | — | — |
Black Diamond Therapeutics quarterly debt-to-assets ratio
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.14 | 0.01 | +8.82% |
| Q1 2026 | 2026-03-31 | 0.13 | 0.01 | +9.84% |
| Q4 2025 | 2025-12-31 | 0.13 | −0.05 | −27.40% |
| Q3 2025 | 2025-09-30 | 0.12 | −0.04 | −25.23% |
| Q2 2025 | 2025-06-30 | 0.12 | −0.03 | −21.34% |
| Q1 2025 | 2025-03-31 | 0.12 | −0.05 | −28.88% |
| Q4 2024 | 2024-12-31 | 0.18 | 0.02 | +13.38% |
| Q3 2024 | 2024-09-30 | 0.17 | 0.02 | +10.40% |
| Q2 2024 | 2024-06-30 | 0.16 | −0.06 | −28.96% |
| Q1 2024 | 2024-03-31 | 0.17 | −0.03 | −14.95% |
| Q4 2023 | 2023-12-31 | 0.16 | −0.02 | −11.41% |
| Q3 2023 | 2023-09-30 | 0.15 | −0.01 | −5.42% |
| Q2 2023 | 2023-06-30 | 0.22 | 0.08 | +53.85% |
| Q1 2023 | 2023-03-31 | 0.20 | 0.07 | +57.34% |
| Q4 2022 | 2022-12-31 | 0.18 | 0.06 | +51.37% |
| Q3 2022 | 2022-09-30 | 0.16 | 0.05 | +47.54% |
| Q2 2022 | 2022-06-30 | 0.15 | 0.09 | +180.90% |
| Q1 2022 | 2022-03-31 | 0.13 | 0.08 | +164.57% |
| Q4 2021 | 2021-12-31 | 0.12 | 0.09 | +348.72% |
| Q3 2021 | 2021-09-30 | 0.11 | 0.08 | +331.82% |
| Q2 2021 | 2021-06-30 | 0.05 | 0.05 | +4551.48% |
| Q1 2021 | 2021-03-31 | 0.05 | 0.05 | +3957.02% |
| Q4 2020 | 2020-12-31 | 0.03 | — | — |
| Q3 2020 | 2020-09-30 | 0.03 | — | — |
| Q2 2020 | 2020-06-30 | 0.00 | — | — |
| Q1 2020 | 2020-03-31 | 0.00 | — | — |
Black Diamond Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Black Diamond Therapeutics's debt-to-assets ratio increased from 0.03 to 0.13, a change of 0.10. The latest reported quarter, Q2 2026, shows 0.14.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Black Diamond Therapeutics source filings ↗